[Lecture] Future issues on dementia in Japan and the world (Cohosted by Japan Medical Association and The Pharmaceutical Research and Manufacturers of America(PhRMA), Dec. 8, 2016)
date : 12/8/2016
Tags: Dementia
Shunichiro Kurita, HGPI Associate was the moderator for the symposium “Future issues on dementia in Japan and the world” cohosted by Japan Medical Association(JMA) and The Pharmaceutical Research and Manufacturers of America(PhRMA).
In this symposium, presentations and a panel discussion were held and discussed the system of supporting people with dementia detected to realize early and precise diagnosis and improve the quality of life. And also they discussed these were necessity of multi-stakeholder cooperation, such as patients, policy makers, JMA, pharmaceutical companies in developing therapeutic agents.
HGPI has recognized dementia as an important issue, has conducted the survey of “Initiative for the Advancement of Dementia Research and Social System Innovation through Global Public Private Partnerships (PPP)”.
For more information
Top Research & Recommendations Posts
- [Recommendations] Proposal on a Global Procurement System for Coronavirus Disease 2019 (COVID-19) Vaccines (September 7, 2020)
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [New Research Project] Initiative for the Advancement of Dementia Research and Social System Innovation through Global Public Private Partnerships (PPP)
- [Recommendations] Proposal on Achieving Better Communication Between Healthcare Providers and Beneficiaries: Building a Flat Healthcare System That Draws Upon Both Sides of Healthcare Equally (September 8, 2020)
- [Research Report] Public Opinion Survey on Priorities for Policies Related to Children’s Health (January 17, 2022)
